PMID- 30366059 OWN - NLM STAT- MEDLINE DCOM- 20200217 LR - 20200217 IS - 1873-4596 (Electronic) IS - 0891-5849 (Linking) VI - 130 DP - 2019 Jan TI - Resveratrol decreases the expression of genes involved in inflammation through transcriptional regulation. PG - 8-22 LID - S0891-5849(18)31488-6 [pii] LID - 10.1016/j.freeradbiomed.2018.10.432 [doi] AB - Oxidative stress generated during inflammation is associated with a wide range of pathologies. Resveratrol (RESV) displays anti-inflammatory and antioxidant activities, being a candidate for the development of adjuvant therapies for several inflammatory diseases. Despite this potential, the cellular responses induced by RESV are not well known. In this work, transcriptomic analysis was performed following lipopolysaccharide (LPS) stimulation of monocyte cultures in the presence of RESV. Induction of an inflammatory response was observed after LPS treatment and the addition of RESV led to decreases in expression of the inflammatory mediators, tumor necrosis factor-alpha (TNF-alpha), interleukin-8 (IL-8), and monocyte chemoattractant protein-1 (MCP-1), without cytotoxicity. RNA sequencing revealed 823 upregulated and 2098 downregulated genes (cutoff >/=2.0 or